These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 22189786)
1. Ingenol mebutate field-directed treatment of UVB-damaged skin reduces lesion formation and removes mutant p53 patches. Cozzi SJ; Ogbourne SM; James C; Rebel HG; de Gruijl FR; Ferguson B; Gardner J; Lee TT; Larcher T; Suhrbier A J Invest Dermatol; 2012 Apr; 132(4):1263-71. PubMed ID: 22189786 [TBL] [Abstract][Full Text] [Related]
2. Ingenol mebutate-mediated reduction in p53-positive keratinocytes in skin cancerization field directly correlates with clinical response in patients with multiple actinic keratoses. Grandi V; di Gennaro P; Torrigiani S; Basco L; Lastrucci I; Pimpinelli N J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1297-1303. PubMed ID: 30801837 [TBL] [Abstract][Full Text] [Related]
3. Analysis of apoptosis-associated molecules Erythroid differentiation regulator 1, bcl-2 and p53 in actinic keratosis after treatment with ingenol mebutate. Woo YR; Lim JH; Jeong SW; Cho DH; Park HJ Exp Dermatol; 2017 Nov; 26(11):1012-1017. PubMed ID: 28370377 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis. Stockfleth E; Bastian M Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):911-918. PubMed ID: 30074409 [TBL] [Abstract][Full Text] [Related]
5. Clinical findings using ingenol mebutate gel to treat actinic keratoses. Martin G; Swanson N J Am Acad Dermatol; 2013 Jan; 68(1 Suppl 1):S39-48. PubMed ID: 23228305 [TBL] [Abstract][Full Text] [Related]
6. Use of ingenol mebutate gel for actinic keratosis in patients in a community dermatology practice. Bettencourt MS J Drugs Dermatol; 2014 Mar; 13(3):269-73. PubMed ID: 24595570 [TBL] [Abstract][Full Text] [Related]
7. Effect of Field Treatment of Actinic Keratosis With Ingenol Mebutate Gel on the Identification of Lesions for Biopsy. Bettencourt MS J Drugs Dermatol; 2015 Aug; 14(8):813-8. PubMed ID: 26267725 [TBL] [Abstract][Full Text] [Related]
8. Ingenol mebutate gel for actinic keratosis. Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254 [TBL] [Abstract][Full Text] [Related]
9. Exploring the use of ingenol mebutate to prevent non-melanoma skin cancer. Erlendsson AM Dan Med J; 2017 Nov; 64(11):. PubMed ID: 29115209 [TBL] [Abstract][Full Text] [Related]
10. Reduced degree of irritation during a second cycle of ingenol mebutate gel 0.015% for the treatment of actinic keratosis. Jim On SC; Haddican M; Yaroshinsky A; Singer G; Lebwohl M Cutis; 2015 Jan; 95(1):47-51. PubMed ID: 25671445 [TBL] [Abstract][Full Text] [Related]
11. Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis. Berman B Expert Opin Drug Saf; 2015; 14(12):1969-78. PubMed ID: 26524598 [TBL] [Abstract][Full Text] [Related]
12. Non-invasive monitoring of subclinical and clinical actinic keratosis of face and scalp under topical treatment with ingenol mebutate gel 150 mcg/g by means of reflectance confocal microscopy and optical coherence tomography: New perspectives and comparison of diagnostic techniques. Ruini C; Hartmann D; Bastian M; Ruzicka T; French LE; Berking C; von Braunmühl T J Biophotonics; 2019 Jul; 12(7):e201800391. PubMed ID: 30653833 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of ingenol mebutate 0.015% gel after cryosurgery of actinic keratosis: 12-month results. Berman B; Goldenberg G; Hanke CW; Tyring SK; Werschler WP; Knudsen KM; Larsson T; Swanson N J Drugs Dermatol; 2014 Jun; 13(6):741-7. PubMed ID: 24918567 [TBL] [Abstract][Full Text] [Related]
14. Effect of ingenol mebutate on actinic keratosis in a Korean population: A prospective clinical, dermoscopic and histopathological study from a single center. Kim JS; Woo YR; Kim M; Park HJ J Dermatol; 2018 Nov; 45(11):1324-1330. PubMed ID: 30260493 [TBL] [Abstract][Full Text] [Related]
15. Syntheses, biological evaluation and SAR of ingenol mebutate analogues for treatment of actinic keratosis and non-melanoma skin cancer. Liang X; Grue-Sørensen G; Månsson K; Vedsø P; Soor A; Stahlhut M; Bertelsen M; Engell KM; Högberg T Bioorg Med Chem Lett; 2013 Oct; 23(20):5624-9. PubMed ID: 23993332 [TBL] [Abstract][Full Text] [Related]
16. Topical Ingenol Mebutate: A New Treatment Modality for Multiple Actinic Keratoses and Field Cancerization. Kostovic K; Gulin SJ; Mokos ZB; Ceovic R Anticancer Agents Med Chem; 2017; 17(10):1304-1311. PubMed ID: 28270072 [TBL] [Abstract][Full Text] [Related]
17. PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study. Siller G; Gebauer K; Welburn P; Katsamas J; Ogbourne SM Australas J Dermatol; 2009 Feb; 50(1):16-22. PubMed ID: 19178487 [TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis. Anderson L; Schmieder GJ; Werschler WP; Tschen EH; Ling MR; Stough DB; Katsamas J J Am Acad Dermatol; 2009 Jun; 60(6):934-43. PubMed ID: 19467365 [TBL] [Abstract][Full Text] [Related]
19. PICATO (ingenol mebutate 0.015% and 0.05% gels): a novel treatment for actinic keratosis. Abramovits W; Oquendo M; Vincent KD; Gupta AK Skinmed; 2013; 11(2):111-5. PubMed ID: 23745230 [No Abstract] [Full Text] [Related]
20. Repeated treatments with ingenol mebutate for prophylaxis of UV-induced squamous cell carcinoma in hairless mice. Erlendsson AM; Thaysen-Petersen D; Bay C; Lerche CM; Philipsen PA; Wulf HC; Zibert JR; Hædersdal M J Photochem Photobiol B; 2016 Oct; 163():144-9. PubMed ID: 27567085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]